The calcium paradox - What should we have to fear?

被引:4
|
作者
Barboza de Oliveira, Marcos Aurelio [1 ]
Brandi, Antonio Carlos [1 ]
dos Santos, Carlos Alberto [1 ]
Husseni Botelho, Paulo Henrique [1 ]
Lasso Cortez, Jose Luis [1 ]
Goissis, Gilberto [1 ]
Braile, Domingo Marcolino [1 ]
机构
[1] Sao Jose do Rio Preto Med Sch FAMERP, Sao Jose Do Rio Preto, SP, Brazil
来源
关键词
Heart Arrest; induced; Myocardial Ischemia; Calcium; PERFUSED RAT-HEART; ENZYME-RELEASE; CARDIAC-MUSCLE; TEMPERATURE-DEPENDENCE; SARCOPLASMIC-RETICULUM; RABBIT MYOCARDIUM; ADULT-RAT; HYPOTHERMIA; CAFFEINE; ULTRASTRUCTURE;
D O I
10.5935/1678-9741.20140054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The calcium paradox was first mentioned in 1966 by Zimmerman et al. Thereafter gained great interest from the scientific community due to the fact of the absence of calcium ions in heart muscle cells produce damage similar to ischemia-reperfusion. Although not all known mechanisms involved in cellular injury in the calcium paradox intercellular connection maintained only by nexus seems to have a key role in cellular fragmentation. The addition of small concentrations of calcium, calcium channel blockers, and hyponatraemia hypothermia are important to prevent any cellular damage during reperfusion solutions with physiological concentration of calcium.
引用
收藏
页码:249 / 254
页数:6
相关论文
共 50 条
  • [21] Professionalism: what is it, why should we have it and how can we achieve it?
    Fricker, J. P.
    Kiley, M.
    Townsend, G.
    Trevitt, C.
    AUSTRALIAN DENTAL JOURNAL, 2011, 56 (01) : 92 - 96
  • [22] Now that we have a direct renin inhibitor, what should we do with it?
    Stanton, Alice
    CURRENT HYPERTENSION REPORTS, 2008, 10 (03) : 194 - 200
  • [23] Now that we have a direct renin inhibitor, what should we do with it?
    Alice Stanton
    Current Hypertension Reports, 2008, 10 : 194 - 200
  • [24] Community genetics: what have we accomplished and where should we be going?
    Hersch-Green, Erika I.
    Turley, Nash E.
    Johnson, Marc T. J.
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2011, 366 (1569) : 1453 - 1460
  • [25] A process control retrospective; What we should have done
    Bristol, EH
    ISA 2002 TECHNOLOGY UPDATE, VOL LVII, PT 1, 2002, 422 : 255 - 262
  • [26] History lesson - What we should have known.
    Peretz, M
    NEW REPUBLIC, 2004, 230 (24) : 25 - 27
  • [27] CHOLANGIOCARCINOMA-WHAT LEVEL OF EVIDENCE SHOULD WE HAVE?
    Abrams, Ross A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (01): : 1 - 2
  • [28] PCSK9 inhibitors: what we know, what we should have understood, and what is to come
    Sabatine, Marc S.
    EUROPEAN HEART JOURNAL, 2022, 43 (07) : E29 - E31
  • [29] Should we fear derivatives?
    Stulz, RM
    JOURNAL OF ECONOMIC PERSPECTIVES, 2004, 18 (03): : 173 - 192
  • [30] Antifungals: what we have, what we will have, what we want
    Martinez-Mendez, Dilia
    Bravo-Acosta, Mariolga
    Semprun-Hernandez, Neomar
    INVESTIGACION CLINICA, 2023, 64 (04): : 539 - 556